TV chef Thomasina Miers says she followed an intermittent low-calorie approach while undergoing chemotherapy, and multiple outlets highlight emerging research suggesting fasting could potentially enhance some cancer treatments.
The coverage notes that lab and early clinical findings are investigating how periods without food or reduced calorie intake may change metabolic and immune responses in ways that could interact with certain therapies. However, the articles do not indicate that fasting is a proven standard of care. Instead, they frame the topic as experimental and dependent on cancer type, treatment regimen, and careful medical supervision.
The differing emphasis is largely about interpretation: one report focuses more on Miers’ personal experience during treatment, while the other foregrounds the scientific rationale and the idea that “fasting” could be explored alongside chemotherapy. Both present fasting as a possible future strategy rather than an established method, and both imply that any dietary changes during cancer therapy should be discussed with healthcare teams.
